Cutler Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-900
Closed -$1K 6481
2021
Q1
$1K Buy
+900
New +$36.6K ﹤0.01% 5421
2020
Q3
Sell
-600
Closed -$1K 5346
2020
Q2
$1K Sell
600
-3,600
-86% -$133K ﹤0.01% 4210
2020
Q1
$46K Buy
4,200
+3,000
+250% +$123K ﹤0.01% 1776
2019
Q4
$1K Buy
+1,200
New +$43.6K ﹤0.01% 3812

Other funds holding ZYME

Cutler Group's ZYME Position: Q1 2024 in Review

Cutler Group sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 1,400 shares — an estimated $14K sold.

Cutler Group first reported a position in ZYME in Q2 2019 and held it in 15 quarters. The position peaked at $187K in Q3 2021. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Cutler Group reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 1,400 Zymeworks shares in Q1 2024, an estimated $14K.
  • Cutler Group first reported a position in Zymeworks in Q2 2019 and held it in 15 quarters.
  • Cutler Group's Zymeworks position peaked at $187K in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.